IL17A and rheumatoid arthritis: In contrast, Lina et al. reported that 12 weeks of combined therapy with Methotrexate and Etanercept decreased the proportion of IL-17+ T cells and serum IL-17 levels in RA subjects, although correlations between IL-17 and disease activity were not assessed38.